New ATAI Life Sciences-DemeRx Joint Venture Seeks To Combat Opioid Use Disorder With Ibogaine

[ad_1]

In 2018, 2.1 million Americans met the diagnostic criteria for opioid use disorder (OUD), with 47,600 people dying from overdoses. Current treatment options for OUD are not only limited, but often carry risk of significant side effects and abuse potential.

In response to this huge unmet medical need, ATAI Life Sciences and DemeRx have announced a joint venture aimed at developing ibogaine for those suffering from opioid addiction.

Ibogaine use traces back to ancient coming-of-age ...

Continue Reading →
Page 19 of 50 «...101718192021...»
UA-77446339-1